{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T03:41:22Z","timestamp":1794454882394,"version":"4.9.1"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2018R1A5A1024340"],"award-info":[{"award-number":["2018R1A5A1024340"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2022M3E5F2017408"],"award-info":[{"award-number":["2022M3E5F2017408"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2022R1C1C2010351"],"award-info":[{"award-number":["2022R1C1C2010351"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Stabilization of hypoxia-inducible factor 1 alpha (HIF1\u03b1), which plays a pivotal role in regulating cellular responses to insufficient oxygen, is implicated in cancer progression, particularly epithelial-mesenchymal transition and metastatic dissemination. Despite its crucial role in tumorigenesis, the precise mechanisms governing HIF1\u03b1 stabilization under varying tumor microenvironmental conditions are not fully understood. In this study, we show that stabilization of HIF1\u03b1 in metastasizing melanoma under mild hypoxia is regulated primarily by mitochondrial reactive oxygen species (ROS) rather than by reduced oxygen levels. Activated HIF1\u03b1 suppresses the expression of cyclophilin D (CypD), a regulator of the mitochondrial permeability transition pore (mPTP), as a reciprocal regulatory mechanism to sustain HIF1 signaling via upregulation of microRNAs miR-23a and miR-27a. Reduced expression of CypD leads to mPTP closure, resulting in elevated mitochondrial calcium accumulation and enhanced oxidative phosphorylation, which in turn increases mitochondrial ROS levels. The ROS then inhibits a prolyl hydroxylase, establishing a pseudohypoxic state that stabilizes HIF1\u03b1 even in the presence of oxygen. This HIF1-reinforced and mitochondria-driven pseudohypoxic induction is essential for maintaining HIF1 signaling under conditions of mild hypoxia or transient increases in oxygen levels during melanoma metastasis. Overexpression of CypD reversed the pseudohypoxic state and potently inhibited melanoma metastasis. Thus, mitochondria-driven pseudohypoxic induction is critical for sustaining HIF1 signaling in metastasizing cancer cells and can be exploited to develop anti-metastatic therapies.<\/jats:p>","DOI":"10.1038\/s41392-025-02314-8","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T23:02:05Z","timestamp":1753311725000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Pseudohypoxic stabilization of HIF1\u03b1 via cyclophilin D suppression promotes melanoma metastasis"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6583-2623","authenticated-orcid":false,"given":"Hye-Kyung","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Yeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sora","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam Gu","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hye","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wonyoung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun-Young","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Heon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0239-2899","authenticated-orcid":false,"given":"Dougu","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5902-0549","authenticated-orcid":false,"given":"Byoung Heon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,24]]},"reference":[{"key":"2314_CR1","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nrc1670","volume":"5","author":"B Weigelt","year":"2005","unstructured":"Weigelt, B., Peterse, J. L., Van, T. & Veer, L. J. Breast cancer metastasis: markers and models. Nat. Rev. Cancer 5, 591\u2013602 (2005).","journal-title":"Nat. Rev. Cancer"},{"key":"2314_CR2","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri, R. & Weinberg, R. A. The basics of epithelial-mesenchymal transition. J. Clin. Investig. 119, 1420\u20131428 (2009).","journal-title":"J. Clin. Investig."},{"key":"2314_CR3","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.tcb.2020.07.003","volume":"30","author":"B Bakir","year":"2020","unstructured":"Bakir, B., Chiarella, A. M., Pitarresi, J. R. & Rustgi, A. K. EMT, MET, plasticity, and tumor metastasis. Trends Cell Biol. 30, 764\u2013776 (2020).","journal-title":"Trends Cell Biol."},{"key":"2314_CR4","doi-asserted-by":"publisher","first-page":"e108647","DOI":"10.15252\/embj.2021108647","volume":"40","author":"S Brabletz","year":"2021","unstructured":"Brabletz, S., Schuhwerk, H., Brabletz, T. & Stemmler, M. P. Dynamic EMT: a multi-tool for tumor progression. EMBO J. 40, e108647 (2021).","journal-title":"EMBO J."},{"key":"2314_CR5","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.trecan.2016.05.006","volume":"2","author":"EB Rankin","year":"2016","unstructured":"Rankin, E. B., Nam, J.-M. & Giaccia, A. J. Hypoxia: signaling the metastatic cascade. Trends Cancer 2, 295\u2013304 (2016).","journal-title":"Trends Cancer"},{"key":"2314_CR6","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev-pathol-020117-043854","volume":"13","author":"V Mittal","year":"2018","unstructured":"Mittal, V. Epithelial mesenchymal transition in tumor metastasis. Annu. Rev. Pathol. 13, 395\u2013412 (2018).","journal-title":"Annu. Rev. Pathol."},{"key":"2314_CR7","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1126\/science.aaf4405","volume":"352","author":"EB Rankin","year":"2016","unstructured":"Rankin, E. B. & Giaccia, A. J. Hypoxic control of metastasis. Science 352, 175\u2013180 (2016).","journal-title":"Science"},{"key":"2314_CR8","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1126\/science.1059796","volume":"292","author":"P Jaakkola","year":"2001","unstructured":"Jaakkola, P. et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292, 468\u2013472 (2001).","journal-title":"Science"},{"key":"2314_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0092-8674(01)00518-9","volume":"107","author":"GL Semenza","year":"2001","unstructured":"Semenza, G. L. HIF-1, O2, and the 3 PHDs. Cell 107, 1\u20133 (2001).","journal-title":"Cell"},{"key":"2314_CR10","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/cdd.2008.10","volume":"15","author":"GH Fong","year":"2008","unstructured":"Fong, G. H. & Takeda, K. Role and regulation of prolyl hydroxylase domain proteins. Cell Death Differ. 15, 635\u2013641 (2008).","journal-title":"Cell Death Differ."},{"key":"2314_CR11","doi-asserted-by":"publisher","first-page":"3263","DOI":"10.1093\/hmg\/ddi359","volume":"14","author":"J-J Bri\u00e8re","year":"2005","unstructured":"Bri\u00e8re, J.-J. et al. Mitochondrial succinate is instrumental for HIF1\u03b1 nuclear translocation in SDHA-mutant fibroblasts under normoxic conditions. Hum. Mol. Genet. 14, 3263\u20133269 (2005).","journal-title":"Hum. Mol. Genet."},{"key":"2314_CR12","doi-asserted-by":"crossref","unstructured":"Chandel, N. S. Mitochondrial regulation of oxygen sensing. Adv. Exp. Med. Biol. 661, 339\u2013354 (2010).","DOI":"10.1007\/978-1-60761-500-2_22"},{"key":"2314_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14795-x","volume":"7","author":"G Beutner","year":"2017","unstructured":"Beutner, G., Alanzalon, R. E. & Porter, G. A. Jr. Cyclophilin D regulates the dynamic assembly of mitochondrial ATP synthase into synthasomes. Sci. Rep. 7, 14488 (2017).","journal-title":"Sci. Rep."},{"key":"2314_CR14","doi-asserted-by":"crossref","unstructured":"Porter, G. A., Jr. & Beutner, G. Cyclophilin D, somehow a master regulator of mitochondrial function. Biomolecules 8, 176 (2018).","DOI":"10.3390\/biom8040176"},{"key":"2314_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25161-x","volume":"12","author":"A Carrer","year":"2021","unstructured":"Carrer, A. et al. Defining the molecular mechanisms of the mitochondrial permeability transition through genetic manipulation of F-ATP synthase. Nat. Commun. 12, 4835 (2021).","journal-title":"Nat. Commun."},{"key":"2314_CR16","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-021-00433-y","volume":"23","author":"M Bonora","year":"2022","unstructured":"Bonora, M., Giorgi, C. & Pinton, P. Molecular mechanisms and consequences of mitochondrial permeability transition. Nat. Rev. Mol. Cell Biol. 23, 266\u2013285 (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2314_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-13-148","volume":"13","author":"HK Park","year":"2014","unstructured":"Park, H. K., Lee, J. E., Lim, J. & Kang, B. H. Mitochondrial Hsp90s suppress calcium-mediated stress signals propagating from mitochondria to the ER in cancer cells. Mol. Cancer 13, 148 (2014).","journal-title":"Mol. Cancer"},{"key":"2314_CR18","doi-asserted-by":"publisher","first-page":"939588","DOI":"10.3389\/fonc.2022.939588","volume":"12","author":"L Zhang","year":"2022","unstructured":"Zhang, L. et al. Cyclophilin D: guardian or executioner for tumor cells? Front. Oncol. 12, 939588 (2022).","journal-title":"Front. Oncol."},{"key":"2314_CR19","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.cell.2007.08.028","volume":"131","author":"BH Kang","year":"2007","unstructured":"Kang, B. H. et al. Regulation of tumor cell mitochondrial homeostasis by an organelle-specific Hsp90 chaperone network. Cell 131, 257\u2013270 (2007).","journal-title":"Cell"},{"key":"2314_CR20","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami, E. et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2, 401\u2013404 (2012).","journal-title":"Cancer Discov."},{"key":"2314_CR21","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 6, pl1 (2013).","journal-title":"Sci. Signal."},{"key":"2314_CR22","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille, S., Xu, J. & Derynck, R. Molecular mechanisms of epithelial\u2013mesenchymal transition. Nat. Rev. Mol. Cell Biol. 15, 178\u2013196 (2014).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2314_CR23","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.molcel.2008.04.009","volume":"30","author":"WG Kaelin Jr.","year":"2008","unstructured":"Kaelin, W. G. Jr. & Ratcliffe, P. J. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol. Cell. 30, 393\u2013402 (2008).","journal-title":"Mol. Cell."},{"key":"2314_CR24","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3109\/10715762.2012.669041","volume":"46","author":"H Niecknig","year":"2012","unstructured":"Niecknig, H. et al. Role of reactive oxygen species in the regulation of HIF-1 by prolyl hydroxylase 2 under mild hypoxia. Free Radic. Res. 46, 705\u2013717 (2012).","journal-title":"Free Radic. Res."},{"key":"2314_CR25","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1172\/JCI120855","volume":"129","author":"JC Chappell","year":"2019","unstructured":"Chappell, J. C., Payne, L. B. & Rathmell, W. K. Hypoxia, angiogenesis, and metabolism in the hereditary kidney cancers. J. Clin. Investig. 129, 442\u2013451 (2019).","journal-title":"J. Clin. Investig."},{"key":"2314_CR26","doi-asserted-by":"crossref","unstructured":"Bernardi, P. et al. Identity, structure, and function of the mitochondrial permeability transition pore: controversies, consensus, recent advances, and future directions. Cell Death Differ. 30, 1869\u20131885 (2023).","DOI":"10.1038\/s41418-023-01187-0"},{"key":"2314_CR27","doi-asserted-by":"publisher","first-page":"5972","DOI":"10.1038\/s44318-024-00259-2","volume":"43","author":"M Protasoni","year":"2024","unstructured":"Protasoni, M. et al. Cyclophilin D plays a critical role in the survival of senescent cells. EMBO J. 43, 5972\u20136000 (2024).","journal-title":"EMBO J."},{"key":"2314_CR28","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.yjmcc.2012.12.004","volume":"56","author":"S Menazza","year":"2013","unstructured":"Menazza, S. et al. CypD-\/- hearts have altered levels of proteins involved in Krebs cycle, branch chain amino acid degradation and pyruvate metabolism. J. Mol. Cell. Cardiol. 56, 81\u201390 (2013).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"2314_CR29","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3389\/fphys.2020.00595","volume":"11","author":"G Amanakis","year":"2020","unstructured":"Amanakis, G. & Murphy, E. Cyclophilin D: an integrator of mitochondrial function. Front. Physiol. 11, 595 (2020).","journal-title":"Front. Physiol."},{"key":"2314_CR30","doi-asserted-by":"publisher","first-page":"3680","DOI":"10.1172\/JCI43171","volume":"120","author":"JW Elrod","year":"2010","unstructured":"Elrod, J. W. et al. Cyclophilin D controls mitochondrial pore-dependent Ca(2+) exchange, metabolic flexibility, and propensity for heart failure in mice. J. Clin. Investig. 120, 3680\u20133687 (2010).","journal-title":"J. Clin. Investig."},{"key":"2314_CR31","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.2741\/3303","volume":"14","author":"RF Feissner","year":"2009","unstructured":"Feissner, R. F., Skalska, J., Gaum, W. E. & Sheu, S. S. Crosstalk signaling between mitochondrial Ca2+ and ROS. Front. Biosci. 14, 1197\u20131218 (2009).","journal-title":"Front. Biosci."},{"key":"2314_CR32","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1042\/BST20230012","volume":"51","author":"SH Lee","year":"2023","unstructured":"Lee, S. H., Duron, H. E. & Chaudhuri, D. Beyond the TCA cycle: new insights into mitochondrial calcium regulation of oxidative phosphorylation. Biochem. Soc. Trans. 51, 1661\u20131673 (2023).","journal-title":"Biochem. Soc. Trans."},{"key":"2314_CR33","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nature10234","volume":"476","author":"JM Baughman","year":"2011","unstructured":"Baughman, J. M. et al. Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter. Nature 476, 341\u2013345 (2011).","journal-title":"Nature"},{"key":"2314_CR34","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/nature10230","volume":"476","author":"D De Stefani","year":"2011","unstructured":"De Stefani, D., Raffaello, A., Teardo, E., Szab\u00f2, I. & Rizzuto, R. A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter. Nature 476, 336\u2013340 (2011).","journal-title":"Nature"},{"key":"2314_CR35","doi-asserted-by":"publisher","first-page":"4949","DOI":"10.1021\/bi00234a016","volume":"30","author":"WL Ying","year":"1991","unstructured":"Ying, W. L., Emerson, J., Clarke, M. J. & Sanadi, D. R. Inhibition of mitochondrial calcium ion transport by an oxo-bridged dinuclear ruthenium ammine complex. Biochemistry 30, 4949\u20134952 (1991).","journal-title":"Biochemistry"},{"key":"2314_CR36","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.cmet.2005.05.001","volume":"1","author":"RD Guzy","year":"2005","unstructured":"Guzy, R. D. et al. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab. 1, 401\u2013408 (2005).","journal-title":"Cell Metab."},{"key":"2314_CR37","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.cmet.2005.05.002","volume":"1","author":"JK Brunelle","year":"2005","unstructured":"Brunelle, J. K. et al. Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. Cell Metab. 1, 409\u2013414 (2005).","journal-title":"Cell Metab."},{"key":"2314_CR38","doi-asserted-by":"publisher","first-page":"30772","DOI":"10.1074\/jbc.M304982200","volume":"278","author":"M Hirsil\u00e4","year":"2003","unstructured":"Hirsil\u00e4, M., Koivunen, P., G\u00fcnzler, V., Kivirikko, K. I. & Myllyharju, J. Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor. J. Biol. Chem. 278, 30772\u201330780 (2003).","journal-title":"J. Biol. Chem."},{"key":"2314_CR39","doi-asserted-by":"publisher","first-page":"39792","DOI":"10.1074\/jbc.M206955200","volume":"277","author":"J Huang","year":"2002","unstructured":"Huang, J., Zhao, Q., Mooney, S. M. & Lee, F. S. Sequence determinants in hypoxia-inducible factor-1alpha for hydroxylation by the prolyl hydroxylases PHD1, PHD2, and PHD3. J. Biol. Chem. 277, 39792\u201339800 (2002).","journal-title":"J. Biol. Chem."},{"key":"2314_CR40","doi-asserted-by":"publisher","first-page":"4082","DOI":"10.1093\/emboj\/cdg392","volume":"22","author":"E Berra","year":"2003","unstructured":"Berra, E. et al. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia. EMBO J. 22, 4082\u20134090 (2003).","journal-title":"EMBO J."},{"key":"2314_CR41","doi-asserted-by":"publisher","first-page":"e1006887","DOI":"10.1371\/journal.pgen.1006887","volume":"13","author":"JL Kurkewich","year":"2017","unstructured":"Kurkewich, J. L. et al. The miR-23a~27a~24-2 microRNA cluster buffers transcription and signaling pathways during hematopoiesis. PLoS Genet. 13, e1006887 (2017).","journal-title":"PLoS Genet."},{"key":"2314_CR42","first-page":"159","volume":"8","author":"J Quan","year":"2018","unstructured":"Quan, J. et al. MicroRNA-23a\/24-2\/27a as a potential diagnostic biomarker for cancer: a systematic review and meta-analysis. Mol. Clin. Oncol. 8, 159\u2013169 (2018).","journal-title":"Mol. Clin. Oncol."},{"key":"2314_CR43","doi-asserted-by":"publisher","first-page":"R155","DOI":"10.1530\/ERC-12-0285","volume":"20","author":"X Wu","year":"2013","unstructured":"Wu, X., Gong, S., Roy-Burman, P., Lee, P. & Culig, Z. Current mouse and cell models in prostate cancer research. Endocr. Relat. Cancer 20, R155\u2013R170 (2013).","journal-title":"Endocr. Relat. Cancer"},{"key":"2314_CR44","doi-asserted-by":"publisher","first-page":"e110744","DOI":"10.1371\/journal.pone.0110744","volume":"9","author":"JR Eun","year":"2014","unstructured":"Eun, J. R. et al. Hepatoma SK hep-1 cells exhibit characteristics of oncogenic mesenchymal stem cells with highly metastatic capacity. PLoS ONE 9, e110744 (2014).","journal-title":"PLoS ONE"},{"key":"2314_CR45","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/ng1634","volume":"37","author":"PB Gupta","year":"2005","unstructured":"Gupta, P. B. et al. The melanocyte differentiation program predisposes to metastasis after neoplastic transformation. Nat. Genet. 37, 1047\u20131054 (2005).","journal-title":"Nat. Genet."},{"key":"2314_CR46","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1158\/0008-5472.CAN-07-2491","volume":"68","author":"KS Hoek","year":"2008","unstructured":"Hoek, K. S. et al. In vivo switching of human melanoma cells between proliferative and invasive states. Cancer Res. 68, 650\u2013656 (2008).","journal-title":"Cancer Res."},{"key":"2314_CR47","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1056\/NEJMra052166","volume":"355","author":"AJ Miller","year":"2006","unstructured":"Miller, A. J. & Mihm, M. C. Jr. Melanoma. N. Engl. J. Med. 355, 51\u201365 (2006).","journal-title":"N. Engl. J. Med."},{"key":"2314_CR48","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1101\/gad.329771.119","volume":"33","author":"F Rambow","year":"2019","unstructured":"Rambow, F., Marine, J. C. & Goding, C. R. Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunities. Genes Dev. 33, 1295\u20131318 (2019).","journal-title":"Genes Dev."},{"key":"2314_CR49","doi-asserted-by":"publisher","first-page":"13679","DOI":"10.1073\/pnas.1712064115","volume":"114","author":"Y Su","year":"2017","unstructured":"Su, Y. et al. Single-cell analysis resolves the cell state transition and signaling dynamics associated with melanoma drug-induced resistance. Proc. Natl. Acad. Sci. USA114, 13679\u201313684 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2314_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6241","volume":"5","author":"L Chen","year":"2014","unstructured":"Chen, L. et al. Metastasis is regulated via microRNA-200\/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression. Nat. Commun. 5, 5241 (2014).","journal-title":"Nat. Commun."},{"key":"2314_CR51","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1158\/0008-5472.CAN-13-1641","volume":"74","author":"A Fantozzi","year":"2014","unstructured":"Fantozzi, A. et al. VEGF-mediated angiogenesis links EMT-induced cancer stemness to tumor initiation. Cancer Res 74, 1566\u20131575 (2014).","journal-title":"Cancer Res"},{"key":"2314_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03505-1","volume":"12","author":"X Bao","year":"2021","unstructured":"Bao, X. et al. The crosstalk between HIFs and mitochondrial dysfunctions in cancer development. Cell Death Dis. 12, 215 (2021).","journal-title":"Cell Death Dis."},{"key":"2314_CR53","doi-asserted-by":"publisher","first-page":"35863","DOI":"10.1074\/jbc.M005643200","volume":"275","author":"FH Agani","year":"2000","unstructured":"Agani, F. H., Pichiule, P., Chavez, J. C. & LaManna, J. C. The role of mitochondria in the regulation of hypoxia-inducible factor 1 expression during hypoxia. J. Biol. Chem. 275, 35863\u201335867 (2000).","journal-title":"J. Biol. Chem."},{"key":"2314_CR54","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1042\/bj20031155","volume":"376","author":"J Mateo","year":"2003","unstructured":"Mateo, J., Garc\u00eda-Lecea, M., Cadenas, S., Hern\u00e1ndez, C. & Moncada, S. Regulation of hypoxia-inducible factor-1\u03b1 by nitric oxide through mitochondria-dependent and -independent pathways. Biochem. J. 376, 537\u2013544 (2003).","journal-title":"Biochem. J."},{"key":"2314_CR55","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1073\/pnas.0808801106","volume":"106","author":"KA O\u2019Hagan","year":"2009","unstructured":"O\u2019Hagan, K. A. et al. PGC-1\u03b1 is coupled to HIF-1\u03b1-dependent gene expression by increasing mitochondrial oxygen consumption in skeletal muscle cells. Proc. Natl. Acad. Sci. USA 106, 2188\u20132193 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2314_CR56","doi-asserted-by":"publisher","first-page":"11715","DOI":"10.1073\/pnas.95.20.11715","volume":"95","author":"NS Chandel","year":"1998","unstructured":"Chandel, N. S. et al. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc. Natl. Acad. Sci. USA 95, 11715\u201311720 (1998).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2314_CR57","doi-asserted-by":"publisher","first-page":"25130","DOI":"10.1074\/jbc.M001914200","volume":"275","author":"NS Chandel","year":"2000","unstructured":"Chandel, N. S. et al. Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1 alpha during hypoxia - a mechanism of O2 sensing. J. Biol. Chem. 275, 25130\u201325138 (2000).","journal-title":"J. Biol. Chem."},{"key":"2314_CR58","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.cmet.2005.05.003","volume":"1","author":"KD Mansfield","year":"2005","unstructured":"Mansfield, K. D. et al. Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-\u03b1 activation. Cell Metab. 1, 393\u2013399 (2005).","journal-title":"Cell Metab."},{"key":"2314_CR59","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1089\/ars.2007.1628","volume":"9","author":"P Vaupel","year":"2007","unstructured":"Vaupel, P., H\u00f6ckel, M. & Mayer, A. Detection and characterization of tumor hypoxia using pO2 histography. Antioxid. Redox Signal. 9, 1221\u20131236 (2007).","journal-title":"Antioxid. Redox Signal."},{"key":"2314_CR60","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1097\/00008390-199710000-00006","volume":"7","author":"E Lartigau","year":"1997","unstructured":"Lartigau, E. et al. Intratumoral oxygen tension in metastatic melanoma. Melanoma Res. 7, 400\u2013406 (1997).","journal-title":"Melanoma Res."},{"key":"2314_CR61","doi-asserted-by":"publisher","first-page":"20130676","DOI":"10.1259\/bjr.20130676","volume":"87","author":"SR McKeown","year":"2014","unstructured":"McKeown, S. R. Defining normoxia, physoxia and hypoxia in tumours\u2014implications for treatment response. Br. J. Radiol. 87, 20130676 (2014).","journal-title":"Br. J. Radiol."},{"key":"2314_CR62","doi-asserted-by":"publisher","first-page":"5928","DOI":"10.1158\/1078-0432.CCR-10-1360","volume":"16","author":"X Lu","year":"2010","unstructured":"Lu, X. & Kang, Y. Hypoxia and hypoxia-inducible factors: master regulators of metastasis. Clin. Cancer Res. 16, 5928\u20135935 (2010).","journal-title":"Clin. Cancer Res."},{"key":"2314_CR63","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nchembio.1185","volume":"9","author":"TH Scheuermann","year":"2013","unstructured":"Scheuermann, T. H. et al. Allosteric inhibition of hypoxia inducible factor-2 with small molecules. Nat. Chem. Biol. 9, 271\u2013276 (2013).","journal-title":"Nat. Chem. Biol."},{"key":"2314_CR64","doi-asserted-by":"publisher","first-page":"9691","DOI":"10.1021\/acs.jmedchem.8b01196","volume":"61","author":"PM Wehn","year":"2018","unstructured":"Wehn, P. M. et al. Design and activity of specific hypoxia-inducible factor-2alpha (HIF-2alpha) inhibitors for the treatment of clear cell renal cell carcinoma: discovery of clinical candidate (S)-3-((2,2-difluoro-1-hydroxy-7-(methylsulfonyl)-2,3-dihydro-1 H-inden-4-yl)oxy)-5-fluorobenzonitrile (PT2385). J. Med. Chem. 61, 9691\u20139721 (2018).","journal-title":"J. Med. Chem."},{"key":"2314_CR65","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41573-023-00848-6","volume":"23","author":"X Yuan","year":"2024","unstructured":"Yuan, X., Ruan, W., Bobrow, B., Carmeliet, P. & Eltzschig, H. K. Targeting hypoxia-inducible factors: therapeutic opportunities and challenges. Nat. Rev. Drug Discov. 23, 175\u2013200 (2024).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2314_CR66","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1158\/0008-5472.CAN-03-3139","volume":"64","author":"A Rapisarda","year":"2004","unstructured":"Rapisarda, A. et al. Topoisomerase I-mediated inhibition of hypoxia-inducible factor 1: mechanism and therapeutic implications. Cancer Res. 64, 1475\u20131482 (2004).","journal-title":"Cancer Res."},{"key":"2314_CR67","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1158\/1535-7163.MCT-07-0463","volume":"7","author":"MY Koh","year":"2008","unstructured":"Koh, M. Y. et al. Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1alpha. Mol. Cancer Ther. 7, 90\u2013100 (2008).","journal-title":"Mol. Cancer Ther."},{"key":"2314_CR68","doi-asserted-by":"publisher","first-page":"3598","DOI":"10.1158\/1535-7163.MCT-08-0510","volume":"7","author":"LM Greenberger","year":"2008","unstructured":"Greenberger, L. M. et al. A RNA antagonist of hypoxia-inducible factor-1\u03b1, EZN-2968, inhibits tumor cell growth. Mol. Cancer Ther. 7, 3598\u20133608 (2008).","journal-title":"Mol. Cancer Ther."},{"key":"2314_CR69","doi-asserted-by":"publisher","first-page":"10418","DOI":"10.1021\/ja402993u","volume":"135","author":"E Miranda","year":"2013","unstructured":"Miranda, E. et al. A cyclic peptide inhibitor of HIF-1 heterodimerization that inhibits hypoxia signaling in cancer cells. J. Am. Chem. Soc. 135, 10418\u201310425 (2013).","journal-title":"J. Am. Chem. Soc."},{"key":"2314_CR70","doi-asserted-by":"crossref","unstructured":"Winkler, J., Abisoye-Ogunniyan, A., Metcalf, K. J. & Werb, Z. Concepts of extracellular matrix remodelling in tumour progression and metastasis. Nat. Commun. 11, 5120 (2020).","DOI":"10.1038\/s41467-020-18794-x"},{"key":"2314_CR71","doi-asserted-by":"crossref","unstructured":"Yi, M. et al. Targeting cytokine and chemokine signaling pathways for cancer therapy. Signal Transduct. Target Ther. 9, 176 (2024).","DOI":"10.1038\/s41392-024-01868-3"},{"key":"2314_CR72","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/0005-2728(71)90153-8","volume":"245","author":"H Degn","year":"1971","unstructured":"Degn, H. & Wohlrab, H. Measurement of steady-state values of respiration rate and oxidation levels of respiratory pigments at low oxygen tensions. a new technique. Biochim. Biophys. Acta 245, 347\u2013355 (1971).","journal-title":"Biochim. Biophys. Acta"},{"key":"2314_CR73","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/380268a0","volume":"380","author":"MI Verkhovsky","year":"1996","unstructured":"Verkhovsky, M. I., Morgan, J. E., Puustein, A. & Wikstrom, M. Kinetic trapping of oxygen in cell respiration. Nature 380, 268\u2013270 (1996).","journal-title":"Nature"},{"key":"2314_CR74","doi-asserted-by":"crossref","unstructured":"Scandurra, F. M. & Gnaiger, E. Cell respiration under hypoxia: facts and artefacts in mitochondrial oxygen kinetics. Adv. Exp. Med. Biol. 662, 7\u201325 (2010).","DOI":"10.1007\/978-1-4419-1241-1_2"},{"key":"2314_CR75","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cell.2007.01.047","volume":"129","author":"R Fukuda","year":"2007","unstructured":"Fukuda, R. et al. HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell 129, 111\u2013122 (2007).","journal-title":"Cell"},{"key":"2314_CR76","doi-asserted-by":"publisher","first-page":"611","DOI":"10.2217\/imt.15.35","volume":"7","author":"DB Johnson","year":"2015","unstructured":"Johnson, D. B., Puzanov, I. & Kelley, M. C. Talimogene laherparepvec (T-VEC) for the treatment of advanced melanoma. Immunotherapy 7, 611\u2013619 (2015).","journal-title":"Immunotherapy"},{"key":"2314_CR77","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 8, 2281\u20132308 (2013).","journal-title":"Nat. Protoc."},{"key":"2314_CR78","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1158\/0008-5472.CAN-18-2558","volume":"79","author":"HK Park","year":"2019","unstructured":"Park, H. K. et al. Interplay between TRAP1 and sirtuin-3 modulates mitochondrial respiration and oxidative stress to maintain stemness of glioma stem cells. Cancer Res. 79, 1369\u20131382 (2019).","journal-title":"Cancer Res."},{"key":"2314_CR79","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"2314_CR80","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li, B. & Dewey, C. N. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinform. 12, 323 (2011).","journal-title":"BMC Bioinform."},{"key":"2314_CR81","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"2314_CR82","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2314_CR83","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."},{"key":"2314_CR84","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/978-1-4939-3578-9_5","volume":"1418","author":"E Clough","year":"2016","unstructured":"Clough, E. & Barrett, T. The gene expression omnibus database. Methods Mol. Biol. 1418, 93\u2013110 (2016).","journal-title":"Methods Mol. Biol."},{"key":"2314_CR85","doi-asserted-by":"publisher","first-page":"100060","DOI":"10.1016\/j.mocell.2024.100060","volume":"47","author":"GY Lee","year":"2024","unstructured":"Lee, G. Y., Ham, S. & Lee, S. V. Brief guide to RNA sequencing analysis for nonexperts in bioinformatics. Mol. Cells 47, 100060 (2024).","journal-title":"Mol. Cells"},{"key":"2314_CR86","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1038\/s41591-019-0654-5","volume":"25","author":"D Liu","year":"2019","unstructured":"Liu, D. et al. Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma. Nat. Med. 25, 1916\u20131927 (2019).","journal-title":"Nat. Med."},{"key":"2314_CR87","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.cell.2017.01.010","volume":"168","author":"W Hugo","year":"2017","unstructured":"Hugo, W. et al. Genomic and transcriptomic features of response to anti-PD-1 therapy in metastatic melanoma. Cell 168, 542 (2017).","journal-title":"Cell"},{"key":"2314_CR88","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","volume":"173","author":"J Liu","year":"2018","unstructured":"Liu, J. et al. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell 173, 400\u2013416 e411 (2018).","journal-title":"Cell"}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02314-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02314-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02314-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T10:52:43Z","timestamp":1757242363000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-025-02314-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,24]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2314"],"URL":"https:\/\/doi.org\/10.1038\/s41392-025-02314-8","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,24]]},"assertion":[{"value":"24 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"231"}}